Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELITE PHARMACEUTICALS INC /NV/ | 0 | reported | 09 Jan 2026 | tx 19+16,719,462−7,219,462 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | EXERCISE | ELITE PHARMACEUTICALS INC /NV/ | 2,500,000 | 0.03 USD | |
| 09 Jan 2026 | EXERCISE | ELITE PHARMACEUTICALS INC /NV/ | 2,500,000 | 0.00 USD | deriv |
| 02 Oct 2025 | SALE | ELITE PHARMACEUTICALS INC /NV/ | 800,000 | 0.62 USD | |
| 08 Jul 2025 | SALE | ELITE PHARMACEUTICALS INC /NV/ | 200,000 | 0.58 USD | |
| 03 Jul 2025 | EXERCISE | ELITE PHARMACEUTICALS INC /NV/ | 2,500,000 | 0.03 USD | |
| 03 Jul 2025 | EXERCISE | ELITE PHARMACEUTICALS INC /NV/ | 2,500,000 | 0.00 USD | deriv |
| 23 Oct 2024 | SALE | ELITE PHARMACEUTICALS INC /NV/ | 800,000 | 0.49 USD | |
| 24 Oct 2024 | SALE | ELITE PHARMACEUTICALS INC /NV/ | 333,932 | 0.51 USD | |
| 03 Jan 2023 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 7,500,000 | 0.03 USD | deriv |
| 20 Aug 2020 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 71,739 | 0.09 USD | |
| 30 Jun 2020 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 574,597 | 0.09 USD | |
| 26 Feb 2018 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 201,717 | 0.12 USD | |
| 23 Feb 2017 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 110,849 | 0.23 USD | |
| 16 Feb 2016 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 47,767 | 0.26 USD | |
| 14 Aug 2015 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 54,169 | 0.23 USD | |
| 23 Jul 2013 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 3,000,000 | 0.00 USD | deriv |
| 27 Apr 2015 | SALE | ELITE PHARMACEUTICALS INC /NV/ | 85,530 | 0.24 USD | |
| 25 Feb 2014 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 85,530 | 0.11 USD | |
| 27 Feb 2015 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 73,094 | 0.34 USD |